If your dog receives Librela for arthritis pain, a new safety update from Australia deserves your attention.
On November 12, 2026, Australia’s veterinary medicine regulator, the APVMA, announced new warnings for Beransa. Beransa and Librela are the same drug, bedinvetmab, with different trade names. Beransa is the name used in Australia; Librela is the name used in the United States and other countries. The update adds concerns about movement, joints, and bones.
What has changed?
The newly listed side effects include:
- Paralysis, or loss of movement.
- Paresis, or partial loss of movement.
- Joint swelling and pain.
- Bone and joint disorders.
- Soft tissue ossification, meaning bone forms in tissues where it normally would not.
The update advises caution in dogs with new or worsening joint pain or swelling after treatment. Other precautions cover existing seizure disorders and certain immune diseases affecting red blood cells, platelets, or joints. Use in dogs with those conditions has not been evaluated.
What does “very rare” mean?
The APVMA places the new side effects in its “very rare” category: fewer than one case per 10,000 animals treated or doses. The agency still considers Beransa to meet its approval standards when used as directed.
For an individual family, though, a serious problem matters even when it is uncommon. These warnings deserve a clear discussion before treatment and during follow-up visits.
Why this matters to me
I want owners to speak up when their dog’s movement changes.
A dog who suddenly struggles to stand, develops a swollen joint, or becomes much more lame needs another examination. We should avoid assuming that every decline is simply age or the usual course of arthritis.
A change after an injection does not, by itself, prove that the medicine caused it. It does give us a reason to investigate, document what happened, and reconsider the treatment plan.
What should owners do?
If your dog receives Beransa or Librela, my advice is:
- Keep a simple record. Note injection dates and changes in walking, comfort, and daily activities.
- Take short videos. Record your dog getting up and walking on a safe, nonslip surface.
- Report new problems promptly. Discuss worsening pain, swelling, weakness, or changes in movement with your veterinarian before another injection.
- Seek urgent care for sudden loss of movement, inability to stand, or a seizure.
Ask your veterinarian to help report a suspected reaction. You do not need to solve the cause yourself before raising a concern.
My goal is to help dogs stay comfortable and mobile while making treatment decisions with their families. That means listening when an owner says, “Something has changed,” and taking the time to find out why.
Source: APVMA safety update, November 12, 2026. This announcement concerns Australian labeling; prescribing information can differ between countries.
Leave a Reply